ReCoDID aims to accelerate the research response to emerging arboviruses and other pathogens by facilitating data and sample sharing between cohort studies.
🌐 The power of collaboration was evident at the final ReCoDID meeting! A truly multidisciplinary team came together for rich conversations on research, showcasing diverse expertise. #ReCoDID
🔬 From data standards to legal challenges, our final meeting delved into the intricacies of infectious disease cohort studies. Kudos to the global team for fostering collaboration and paving the way for future advancements
Give the portal a try for yourself and check out the user-friendly features including flexible search, publication information, images, and quick access to related project data portals.
ebi.ac.uk/biodiversity/
The Global Biodiversity Portal has launched!
Get access to raw data, genome assemblies, and annotations, and track the status of your species of interest sequenced as part of @EBPgenome.
ebi.ac.uk/about/news/announc…
In case you missed it, find out more about our newly launched Pathogens Portal, a comprehensive collection of #pathogen data from around the world.
@CORDIS_EU story: europa.eu/!QcRyrP
From diagnosis challenges to pregnancy termination policies, highlighting the critical role of guidelines in public health interventions. #ZIKVResponse#ReCoDIDResearch
📊 Fascinating insight! Examining ZIKV policies during the 2015-18 epidemic, a #ReCODID researcher presented a poster revealing disparities of responses from various countries included in the ZIKAlliance.
With vaccines on the horizon, we're leveraging natural history cohorts to solidify evidence. Join us in mapping out crucial steps for future readiness! #ZIKVResearch#ReCoDID
🔬 From data consolidation to readiness for re-emergence-Sundays panel discussion symposium at #ASTMH showcased a deep dive into maternal ZIKV infection during pregnancy and its impact on birth outcomes.
🌍 Exciting developments at the ASTMH conference! #ReCODID researchers delved into the world of ZIKV birth cohort studies, assessing risks and outcomes. As vaccines and antibodies emerge, our mission is to consolidate insights, bridge gaps, and prepare for potential re-emergence
🤝Thanks to the @erasmusmcintl, which provided the first dataset through the @ReCoDID2 project, the first cohort study linking data from different categories for SARS-CoV-2 is now available in the Pathogens Portal Cohort Browser !
➡️ ebi.ac.uk/ena/pathogens/v2/c…
COVID-PRECISE🦠
Clinical prediction models for mortality in COVID-19 patients: an external validation and individual participant data meta-analysis🧬
For more informations 👉onlinelibrary.wiley.com/doi/…#Covid19#Data#Metanalysis
Update WP 3 & 8 Cohorts – some highlights 💪
WP3: Arbovirus Cohorts
WP8: COVID-19 Cohorts
To discover the new projects 👉 Link
#WorkPackages#CohortData#COVID19